Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for December 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Three Novel Loci Associated With Polycystic Ovary Syndrome ID’d
MONDAY, Dec. 31, 2018 (HealthDay News) — Three novel loci have been identified for polycystic ovary syndrome (PCOS), according to research published online Dec. 19 in PLOS Genetics.
Incidence of End-Stage Kidney Disease Up in Australia
MONDAY, Dec. 31, 2018 (HealthDay News) — For nonindigenous people with type 2 diabetes mellitus (T2DM) in Australia, the age-standardized incidence of end-stage kidney disease (ESKD) increased from 2002 to 2013, according to a study published online Dec. 19 in the American Journal of Kidney Diseases.
Abstract/Full Text (subscription or payment may be required)
Second-Line Antidiabetic Meds May Impact Cardiovascular Risk
FRIDAY, Dec. 28, 2018 (HealthDay News) — For adults with type 2 diabetes initiating second-line antidiabetic medications (ADM), cardiovascular risk is increased with use of sulfonylureas or basal insulin versus newer ADM classes, according to a study published online Dec. 21 in JAMA Network Open.
Pregnancy Complications Up for Women Born at Low Birth Weight
FRIDAY, Dec. 28, 2018 (HealthDay News) — Women born with a low birth weight have an increased risk for pregnancy complications, according to a study published online Dec. 19 in Obesity.
Abstract/Full Text (subscription or payment may be required)
Sugar-Sweetened Drinks Linked to Chronic Kidney Disease Risk
FRIDAY, Dec. 28, 2018 (HealthDay News) — A pattern of higher consumption of sugar-sweetened beverages is associated with increased odds of chronic kidney disease (CKD), according to a study published online Dec. 27 in the Clinical Journal of the American Society of Nephrology.
Targeted Muscle Reinnervation Can Reduce Phantom Limb Pain
THURSDAY, Dec. 27, 2018 (HealthDay News) — Use of primary targeted muscle reinnervation (TMR) can prevent or reduce pain in below-the-knee amputees, according to a report published online Dec. 27 in Plastic and Reconstructive Surgery.
Abstract/Full Text (subscription or payment may be required)
Low-Priced Generic Drugs Most Likely to Have Shortages
THURSDAY, Dec. 27, 2018 (HealthDay News) — The lowest-priced generic drugs are more likely to experience shortages, according to a study published in the November issue of Value in Health.
Abstract/Full Text (subscription or payment may be required)
Initiative Can Cut Gender Gap in Medical School Faculty Salaries
WEDNESDAY, Dec. 26, 2018 (HealthDay News) — An institutional gender equity initiative (GEI) can reduce gender-based salary gaps among medical school faculty, according to a study published online Dec. 21 in JAMA Network Open.
Vascular Burden in Midlife Linked to Increased Risk for Dementia, Death 
GLP-1 Receptor Agonists Tied to Increased Risk for Alopecia 
Food-Based Support Aids Type 2 Diabetes Outcomes 
Hypoglossal Nerve Stimulation May Offer Long-Term Cardiovascular Benefits in OSA 
Therapeutic Hypothermia Duration Explored in Comatose OHCA Survivors 
28 Percent of U.S. Adults With HTN Eligible for Treatment Under New Guidelines 
Press-Needle Therapy Shows Potential for Pediatric Allergic Rhinitis 
Burden of Myocardial Dysfunction Elevated for Individuals With Psoriasis 
